← Back to Search

Behavioural Intervention

Patient Involvement for Low Blood Sugar

N/A

Recruiting

Led By Scott J Pilla, MD, MHS

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to immediately after the intervention

Awards & highlights

Study Summary

This trial aims to test a program that helps prevent low blood sugar in patients taking medications that can cause it. The study will assess how well the program is accepted and if it is feasible in a primary

Who is the study for?

This trial is for individuals with low blood sugar or diabetes who are currently on medications that can cause hypoglycemia. Details about specific inclusion and exclusion criteria are not provided, but typically participants need to meet certain health conditions.Check my eligibility

What is being tested?

The study tests a new program aimed at preventing low blood sugar in patients. It involves groups of primary care physicians, patients, and clinic staff working together. The goal is to see if the program works well in a real-world setting before planning a larger trial.See study design

What are the potential side effects?

Since this trial focuses on a prevention program rather than medication, it may not have direct side effects like drugs do. However, changes in how low blood sugar is managed could potentially lead to varying levels of blood sugar control.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to immediately after the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to immediately after the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to immediately after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Overall acceptability to clinic staff

Overall acceptability to patients

Overall acceptability to primary care providers

Other outcome measures

Affective attitude (patients)

Affective attitude (primary care providers)

Burden (clinic staff)

+33 more

Trial Design

3Treatment groups

Experimental Treatment

Group I: Primary Care Physician (PCP) InvolvementExperimental Treatment1 Intervention

PCPs will be given access to the Hypoglycemia Prevention toolkit

Group II: Patient InvolvementExperimental Treatment1 Intervention

Patients who participate in the study will undergo one Baseline Clinic Visit (baseline usual care), and one Intervention clinic visit.

Group III: Clinic Staff InvolvementExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor

2,267 Previous Clinical Trials

14,837,527 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,360 Previous Clinical Trials

4,314,817 Total Patients Enrolled

Scott J Pilla, MD, MHSPrincipal InvestigatorJohns Hopkins University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical study currently open for enrollment?

"Affirmative. The details listed on clinicaltrials.gov underscore the active pursuit of participants for this research project. It was first shared on April 1st, 2024 and most recently revised on April 5th, 2024. To complete the study, they aim to enlist a total of 35 individuals from one designated site."

Answered by AI

What is the current number of participants enrolled in this research study?

"Indeed, as per the details on clinicaltrials.gov, this trial is actively in search of suitable candidates. The trial was first uploaded on 4/1/2024 and underwent its most recent revision on 4/5/2024. It aims to recruit a total of 35 participants from a single designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Study of a Primary Care Hypoglycemia Prevention Program

2024. "Study of a Primary Care Hypoglycemia Prevention Program". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06353217.

All > Hypoglycemia > Philadelphia